Consequently, the manipulation of BDNF-AS, e.g., under hypoxia and oxidative stress conditions, will have an effect on the protective mechanisms of BDNF, suggesting BDNF-AS as a possible target in the treatment of hypoxia–ischemia-induced brain damage [14]. This evidence concerns the gene BDNF and ischemia.